fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹156.909 ↓ -1.54  (-0.97 %) as on 14 May 21

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.9% since its launch.  Ranked 40 in Sectoral category.  Return for 2020 was 67.4% , 2019 was 1.2% and 2018 was -7.5% .

Below is the key information for UTI Healthcare Fund

NAV as on 14 May 21₹156.909 ↓ -1.54  (-0.97 %)
Net Assets (AUM) as on 31 Mar 2021 ₹618 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio0.88
Expense Ratio2.59 %
Sharpe Ratio2.061
Information Ratio0.18
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 May 21

DurationReturns
1 Month 8.5%
3 Month 11%
6 Month 20.8%
1 Year 58.1%
3 Year 24%
5 Year 12.3%
10 Year
15 Year
Since launch 14.9%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%

Growth of 10k Over Years

DateValue
30 Apr 16₹10,000
30 Apr 17₹9,832
30 Apr 18₹9,827
30 Apr 19₹9,784
30 Apr 20₹11,306
30 Apr 21₹17,201
UTI Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash1.63%
Equity98.37%
UTI Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care95.35%
Basic Materials3.03%
UTI Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic10%₹59 Cr669,805
↑ 13,783
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic10%₹59 Cr982,457
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - General9%₹59 Cr720,104
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
Drug Manufacturers - Specialty & Generic8%₹52 Cr115,140
↑ 11,782
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic6%₹39 Cr106,427
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
Drug Manufacturers - Specialty & Generic6%₹35 Cr578,554
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
Drug Manufacturers - Specialty & Generic5%₹33 Cr754,423
↑ 62,731
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
Medical Care Facilities4%₹27 Cr1,367,122
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
Drug Manufacturers - Specialty & Generic4%₹25 Cr141,398
J.B. Chemicals & Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Dec 20 | 506943
Drug Manufacturers - Specialty & Generic4%₹22 Cr176,777
↑ 33,179
1 - 10 of 28
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
V Srivatsa3 Mar 174.16 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹156.909
↓ -1.54
20.84 %58.12 %24.01 %12.34 %
UTI Healthcare Fund
Normal Dividend, Payout
₹121.269
↓ -1.19
20.84 %58.12 %24.01 %12.34 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹121.269
↓ -1.19
20.84 %58.12 %24.01 %12.34 %
Data as on 14 May 21

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.